Last reviewed · How we verify

NCT06744803

The Effect of a Gamified Neuropathy Management Application on Cancer Behavior in Cancer Patients Undergoing Chemotherapy

Not yet recruiting NA Last updated 20 December 2024
What this trial tests

NA trial testing Gamified Neuropathy Management Application on Cancer Behavior in Cancer in 60 participants. Not yet recruiting.

Timeline
1 January 2025
Primary endpoint
30 August 2025
31 December 2025

Quick facts

Lead sponsorAnkara Yildirim Beyazıt University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment60
Start date1 January 2025
Primary completion30 August 2025
Estimated completion31 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara Yildirim Beyazıt University

Who can join

Adults 18 to 65, any sex, with Cancer or Chemotherapy Induced Pain Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to determine the effect of a gamified neuropathy management application on cancer behavior in cancer patients undergoing chemotherapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Ankara Yildirim Beyazıt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06744803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing